When Satya Nadella, president of MS, asked Peter Lee to reconsider the company's medical strategy two and a half years ago, Lee was suspicious.
Lee's vice president, Lee, told an interview with Matt Turner, editor-in-chief of Business Insider, at the annual conference in Davos, the World Economic Forum, Nadella took the pressure right away, and it's not easy. Tech companies such as Microsoft have historically been struggling with their medical business.
For example, we created Google Health, a personal health information service, but the project ended in 2011. Microsoft created a version called HealthVault, but eventually it did not work.
"The high-tech industry is covered by shiny CEOs trying to follow a part of this huge medical institution," Lee said. "I think the technology industry has worked quite consistently with a lot of arrogance and even a bit of arrogance, so I think a kneeling family is going back here."
Read more: The hospital in the backyard of Amazon plans to get confused before it gets confused by big tech companies.
To avoid past mistakes, Lee and his team had to think hard about the role Microsoft could play in health care.
"I am a fundamental question about what a company like Microsoft is entitled to participate in health care.
In other words, Lee says: If Microsoft is going to disappear tomorrow, in what ways will the healthcare industry be harmed? "It took some time to overcome the emotional response to health care, team up and investigate the problem," Lee said.
Now he and his team are completely in medical care.
"We not only get excited about business and technology, but we know we have an important mission in the medical field," he said.
Many health data already take up a lot of storage space. For example, to store a single human genome requires up to 200 gigabytes.
Your entire genome is full of much information. We still do not know how to interpret it. Most genetic tests that report information about their traits or ancestors focus primarily on collecting single nucleotide polymorphisms (SNPs), which are specific mutations that are primarily associated with a particular trait or condition.
So now only a few people are sequencing the entire genome. But deciphering more useful information in our genes will start to grow. And companies like Microsoft will need to store that data.
"We know this is going to spread," Lee said. "When the hyper-scale computing infrastructure that Microsoft and a handful of other companies have is actually expanding, that will be important."